A61P 37 - Drugs for immunological or allergic disorders

Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
10/2011
10/26/2011	EP2379497A1 Hemifumarate salt of 1- ý4- ý1- ( 4 -cyclohexyl-3 -trifluoromethyl-benzyloxyimino ) -ethyl¨-2 -ethyl-benzyl¨-a zetidine-3-carboxylic acid
10/26/2011	EP2379069A1 Dosage regimen of an s1p receptor agonist
10/26/2011	EP2379067A1 Dosage regimen for a s1p receptor agonist
10/26/2011	EP2139894B1 9-substituted-8-oxo-adenine compounds as toll-like receptor (tlr7) modulators
10/26/2011	EP2120590B1 Use of lactobacillus casei for increasing the protection provided by the influenza vaccine
10/26/2011	EP2046835B1 Antibodies to il-17a
10/26/2011	EP1916245B1 Indole derivative having pgd2 receptor antagonist activity
10/26/2011	EP1617867B1 Immunomodulating composition comprising a particulate fraction of bacterial mechanical lysates
10/26/2011	EP1292321B1 Method to increase class i presentation of exogenous antigens by human dendritic cells
10/26/2011	EP1060247B2 Ox-40 receptor binding agent for use in methods for enhancing tumour antigen-specific immune response
10/26/2011	EP0787191B2 Nucleotide sequences of hiv-1 type (or subtype) o retrovirus antigens
10/26/2011	CN102227409A Pyridine-3-carboxyamide derivative
10/26/2011	CN102227224A Th1 vaccination priming for active immunotheraphy
10/26/2011	CN102227223A Mineral absorption improver, and method for improving absorption of minerals
10/26/2011	CN102226137A Nourishing health care wine
10/26/2011	CN102225923A Method for preparing dihydromyricetin from Ampelopsis grossedentata
10/26/2011	CN102225200A Methods and compositions for modulating TWEAK and FN14 activity
10/26/2011	CN102225194A Use of Bv8 and/or EG-VEGF to promote hematopoiesis
10/26/2011	CN102225182A Traditional Chinese preparation capable of inhibiting tumor and enhancing immunity and preparation method thereof
10/26/2011	CN102225153A Traditional Chinese medicine composition for treating systemic lupus erythematosus and preparation method thereof
10/26/2011	CN102225118A Blood-activating wind-dispelling liquid
10/26/2011	CN102225094A Compound immunopotentiator for controlling hemorrhagic edema in yellow catfish as well as preparation method and application thereof
10/26/2011	CN102225093A Preparation of Magnolia flower volatile oil soft capsule for treating allergic rhinitis and associated diseases
10/26/2011	CN102225084A Processing process of Chinese medicinal decoction pieces of dogbane leaves
10/26/2011	CN102225074A Injection for treating spring allergy and allergic asthma and preparation method thereof
10/26/2011	CN102225073A Injection for treating spring allergy and allergic asthma and preparation method thereof
10/26/2011	CN102224989A Water bed
10/26/2011	CN101926900B Pediluvium composition and preparing method thereof
10/26/2011	CN101869590B Chinese medicinal herba epimedii and propolis flavone immunopotentiator
10/26/2011	CN101857646B Method for extracting high-purity beta-glucan and whole oat flour from oat bran
10/26/2011	CN101851291B Heavy chain and light chain variable regions of anti-human BAFF monoclonal antibody
10/26/2011	CN101816694B Echinacea purpurea oral liquid and preparation method and application thereof
10/26/2011	CN101676266B Deuterium-substituted omega-diphenylurea and its derivatives, as well as pharmaceutical composition containing the same
10/26/2011	CN101647852B Veterinary medicine for enhancing immunologic function
10/26/2011	CN101589761B Preparation method and application of industrial hemp seed antioxidant peptide
10/26/2011	CN101301344B Oral Chinese medicine for treating blood-heat drug induced dermatitis
10/26/2011	CN101185686B Powder agent medicine for treating eczema
10/25/2011	US8044188 Genetically engineered clostridial genes, proteins encoded by the engineered genes, and uses thereof
10/25/2011	US8044182 Adiponectin and uses thereof
10/25/2011	US8044056 Adenine compound
10/25/2011	US8044042 Thienotriazolodiazepine compound and medicinal use thereof
10/25/2011	US8044040 e.g. 3-{3-Cyano-6-[(2,2-dimethyl-propyl)-methyl-amino]-5-fluoro-pyridin-2-ylamino}-N-methoxy-4-methyl-benzamide; via p38 kinase inhibition; (anilino)(halo)pyrimidine or (anilino)(amino)pyrimidine derivatives; rheumatoid arthritis, psoriasis, Crohn's Disease, osteoarthritis or osteoporosis
10/25/2011	US8043855 vector contains an adenoviral genome from which the open reading frames E1 and/or E3 have been deleted, but retains enough sequence to make it able to replicate in vitro; also contains a DNA sequence regulated by promoters that encode for fibrosis treatment proteins
10/25/2011	US8043628 biodegradable drug delivery system containing an immunosuppressive agent and a bioerodible polymer comprising hydroxyaliphatic carboxylic acids, and polysaccharides
10/25/2011	US8043624 Compositions and methods for treatment of microbial infections
10/25/2011	US8043608 Methods of using Fc-cytokine fusion proteins
10/25/2011	CA2505538C Papaya puree and its use
10/22/2011	CA2700466A1 Modification of intrinsically disordered sequences for the preparation of vaccines
10/20/2011	WO2011130613A1 Targeted pyrrolobenzodiazapine conjugates
10/20/2011	WO2011130390A1 2, 4-pyrimidinediamine compounds and prodrugs thereof and their uses
10/20/2011	WO2011130379A1 Benzonapthyridine compositions and uses thereof
10/20/2011	WO2011130146A1 5, 7-substituted-imidazo [1, 2-c] pyrimidines as inhibitors of jak kinases
10/20/2011	WO2011129348A1 Composition for treatment of cancer which is produced from cancer-tissue-derived cell mass or cancer cell aggregate, and process for production of immunotherapeutic agent and method for evaluation of efficacy of immunotherapy both using the composition
10/20/2011	WO2011128905A1 Novel nutraceutical formulation isolated from the plants of family scrophulariaceae as anticancer, antiviral, antiaging and immunostimulating agent
10/20/2011	WO2011128429A1 Antagonists for the prevention or treatment of inflammatory bowel disease, and more particularly of crohn's disease
10/20/2011	WO2011127625A1 Method for regulating microrna content in organisms and uses thereof
10/20/2011	WO2011127543A1 Proteins that bind pi16 and uses thereof
10/20/2011	WO2011034896A3 Small molecule inhibitors of the alpha4-paxillin interaction
10/20/2011	WO2010117829A8 Differentially expressed micrornas as biomarkers for the diagnosis and treatment of sjögren's syndrome
10/20/2011	US20110258713 Compositions and methods for re-programming cells without genetic modification
10/20/2011	US20110257458 Method of using tumor cell debris to reduce brain tumor recurrence or growth
10/20/2011	US20110257238 Heteroaryl Dihydroindolones as Kinase Inhibitors
10/20/2011	US20110257222 Compounds and methods for the treatment of pain and other diseases
10/20/2011	US20110257208 Compounds useful as faah modulators and uses thereof
10/20/2011	US20110257203 Inhibitors of bruton's tyrosine kinase
10/20/2011	US20110257176 Nitrogen heterocycle derivatives as proteasome modulators
10/20/2011	US20110257171 Novel imidazo[1,2-a]pyridine derivatives, method for the preparation thereof, use thereof as medicaments, pharmaceutical compositions and novel use in particular as met inhibitors
10/20/2011	US20110257170 4-morpholino-pyrido[3,2-d]pyrimidines
10/20/2011	US20110257150 New salts
10/20/2011	US20110257137 Heterocyclic inhibitors of histamine receptors for the treatment of disease
10/20/2011	US20110257126 Water soluble curcumin compositions for use in anti-cancer and anti-inflammatory therapy
10/20/2011	US20110257115 Method for treating rhinitis and sinusitis by rhamnolipids
10/20/2011	US20110257110 Composition comprising a glycoside of a mono- or diacylglycerol compound and an oil rich in n-3 polyunsaturated fatty acids, a method of producing the composition and use of the composition
10/20/2011	US20110257104 Methods to identify macromolecule binding and aggregation prone regions in proteins and uses therefor
10/20/2011	US20110257103 Compositions and methods for the treatment of sj?rgren's syndrome
10/20/2011	US20110257085 Crystal Forms of Saxagliptin and Processes for Preparing Same
10/20/2011	US20110256246 Essential oil of kunzea ambigua and methods of use
10/20/2011	US20110256229 Rapid-acting pharmaceutical composition
10/20/2011	US20110256214 Single-time vaccines
10/20/2011	US20110256213 Phospholipid micellar and liposomal compositions and uses thereof
10/20/2011	US20110256190 Modified release compositions comprising tacrolimus
10/20/2011	US20110256180 Factor H Binding Proteins (FHBP) with Altered Properties and Methods of Use Thereof
10/20/2011	US20110256179 Pharmaceutical preparation comprising a combination of streptococcus strains and lactobacillus strains
10/20/2011	US20110256178 Borrellia burgdorferi bacterin
10/20/2011	US20110256177 Yersinia pestis vaccine
10/20/2011	US20110256176 Herpes simplex virus combined subunit vaccines and methods of use thereof
10/20/2011	US20110256175 Amino lipids and methods for the delivery of nucleic acids
10/20/2011	US20110256174 Rabies vaccine
10/20/2011	US20110256173 Chemical synthesis of phosphatidylinositol mannoside glycans from mycobacterium tuberculosis
10/20/2011	US20110256172 Epitope-targeted anthrax vaccine
10/20/2011	US20110256169 Novel polypeptides related to b-type natriuretic peptides and methods of their identification and use
10/20/2011	US20110256168 Conjugates that Contain the Homeodomain of Antennapedia
10/20/2011	US20110256165 Compositions of hsp60 peptides and viral antigens for vaccination and diagnosis
10/20/2011	US20110256163 Identification, optimization and use of cryptic hla-b7 epitopes for immunotherapy
10/20/2011	US20110256161 Methods for enhancing immune response
10/20/2011	US20110256160 Adherent cells from placenta tissue and use thereof in therapy
10/20/2011	US20110256159 Adherent cells from placenta tissue and use thereof in therapy
10/20/2011	US20110256158 Novel use of an il-12 receptor splice variant and molecular assay to quantify expression thereof
10/20/2011	US20110256151 Antibodies to human il-1beta
10/20/2011	US20110256149 Antibody formulation

1 ... 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 ... 1172